Creative Medical Technology Holdings, Inc. APIC, Share-based Payment Arrangement, Increase for Cost Recognition
Creative Medical Technology Holdings, Inc. (CELZ) reported APIC, Share-based Payment Arrangement, Increase for Cost Recognition of $3.48 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-20.
Financial Statements › Shareholders' Equity
us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue · last filed 2026-08-07
- Creative Medical Technology Holdings, Inc. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2025-06-30 was $0.00.
- Creative Medical Technology Holdings, Inc. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2025-03-31 was $3.48K.
- Creative Medical Technology Holdings, Inc. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2018-12-31 was $0.00.
- Creative Medical Technology Holdings, Inc. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2018-09-30 was $0.00.
- Creative Medical Technology Holdings, Inc. apic, share-based payment arrangement, increase for cost recognition for fiscal 2025 was $3.48K, a 90.49% decline from fiscal 2024.
- Creative Medical Technology Holdings, Inc. apic, share-based payment arrangement, increase for cost recognition for fiscal 2024 was $36.65K.
- Creative Medical Technology Holdings, Inc. apic, share-based payment arrangement, increase for cost recognition for fiscal 2018 was $1.88K, a 94.07% decline from fiscal 2017.
- Creative Medical Technology Holdings, Inc. apic, share-based payment arrangement, increase for cost recognition for fiscal 2017 was $31.66K, a 1134.31% increase from fiscal 2016.
| Period end | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 3 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 6 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 9 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 12 month |
|---|---|---|---|---|
| 2025-12-31 | $3.48K 10-K · filed 2026-03-20 | |||
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | $3.48K 10-Q · filed 2026-08-07 | ||
| 2025-03-31 | $3.48K 10-Q · filed 2026-05-08 | |||
| 2024-12-31 | $36.65K 10-K · filed 2026-03-20 | |||
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-04-06 | $0.00 derived: sum of 2 quarters · filed 2020-04-06 | $0.00 derived: sum of 3 quarters · filed 2020-04-06 | $1.88K 10-K · filed 2020-04-06 |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-14 | $0.00 derived: sum of 2 quarters · filed 2019-11-14 | $1.88K 10-Q · filed 2019-11-14 | |
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-13 | $1.88K 10-Q · filed 2019-08-13 | ||
| 2018-03-31 | $1.88K 10-Q · filed 2019-05-20 | |||
| 2017-12-31 | $31.66K 10-K · filed 2019-04-01 | |||
| 2016-12-31 | $2.56K 10-K · filed 2018-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Silexion Therapeutics Corp (SLXN) | $0.001B |